Keep up to date with all the latest ARMI news and events. We know your inbox is overflowing, so we promise to only share important news and events with you – we hate SPAM too.
ARMI people
Exclusive award for optimistic Australian researcher The Nilsson Groups’s Ben Cao was optimistic when he applied for the 2017 Gilead Sciences International Research Scholars Program in Hematology/Oncology, but knew just how competitive it was. He was thrilled to be announced as one of the first Australian researchers to receive the award, which provides funding over 2 years. “The research […]
ARMI to lead research for international company
The Australian branch of Cell Mogrify, a company that drastically reduces the time it takes to reprogram cells, is run by A/Prof Jose Polo, Associate Professor and group leader at ARMI. In 2006, Japanese researchers stunned the world by showing that mature cells could be reprogrammed to become induced pluripotent stem cells, which could then, […]
Matter of the heart: Spotlight on Dr Janine Kirk
We sat down with Dr Janine Kirk, Chair of ARMILAB, to discuss her reasons for taking an active leadership role with the Institute and her hopes for ARMI. Dr Janine Kirk is chair of The Australian Regenerative Medicine Institute Leadership Advisory Board (ARMILAB), which works with senior management and liaises with key stakeholders. She brings […]
Artists have arrived at ARMI
The ARMI Artist in Residence Program has begun, with four artists visiting the Institute. Successful applicants have one week’s full access to the Institute, supervised access to labs, and can pick the brains of scientists at the cutting edge of regenerative medicine research for inspiration. A sneak peak of some of each of the artists’ […]
ARMI announces quail facility to study skeletal muscle regeneration
In June 2016, Dr Olivier Serralbo received ARMI’s first shipment of quails – the start of a yearlong process to build the Monash Transgenic Quail Facility (MTQF) at ARMI, a significant step in fast-tracking our understanding of skeletal muscle regeneration.​ This work has been a while in the making – Dr Serralbo and Professor Marcelle […]
International bioinformatics competition proves high thinkability
Thinkable, an online innovation platform that allows organisations to source, showcase & celebrate the latest research from across the world, has joined forces with The Australian Regenerative Medicine Institute (ARMI) at Monash University, Centre for Systems Genomics at the University of Melbourne and Melbourne Bioinformatics to host their first global ‘Peer Prize’ for bioinformatics. ARMI […]
ARMI Opens the Vault, opening up a conversation on regenerative medicine
Scientists in regenerative medicine have two choices: to champion the technology to the public, ensure an acknowledgement and public understanding of the risks and benefits that exist, to ultimately negotiate approval through constant and sincere public engagement – or not. If we fail to maintain public support for regenerative medicine research, approval for regenerative medicine […]
Regenerate Newsletter – Autumn Edition 2017
Here are just some of the highlights for ARMI in the first quarter of 2017: Everyone loves a giant cheque: To end 2016, ARMI celebrated its first ever crowd funding for Muscular Dystrophy research – with a cheque presentation. ARMI partnered up with the crowd funding team Charidy to successfully beat an initial target of $10,000 […]
The Bioinformatics Peer Prize is now open for submissions
In partnership with the Centre for Systems Genomics, ARMI and Melbourne Bioinformatics, Thinkable is excited to launch the inaugural ‘Peer Prize’ for bioinformatics. The objective is to accelerate wider knowledge exchange & drive multi-disciplinary collaboration with the latest bioinformatics research from around the world, while celebrating the most exciting new discoveries made in the field as voted by […]
ARMI researchers unlock new therapy to improve outcomes for stroke patients
ARMI researchers unlock new therapy to improve outcomes for stroke patients. A potential regenerative medicine therapy could decrease disability in people after stroke and other brain injuries. The new therapy is based on a naturally occurring molecule called ephrin-A1 and is most effective when given one week after a stroke, says Associate Professor James Bourne, […]